Blood samples were collected from all subjects available at years 8.5 and/or 10 for the assessment of antibody persistence. A third blood sample was collected one month after the booster dose. Samples were stored at −20 °C until shipment to GlaxoSmithKline's laboratories in Belgium and Quebec for testing.